The PI spoke with the PO about using personnel funds to pay a modest amount (cover parking, e.g.) to some high school students with whom he is working. I was concerned about paying high school students since
we had budgeted undergrad and grad students and a key focus of R15s is to expose undergrads to research. Apparently the high school students aren’t a problem.
Based on yours and Michael’s responses, I would say that my understanding was not faulty.
Thanks, Scott and Michael.
Carolyn
From: Research Administration List <xxxxxx@lists.healthresearch.org>
On Behalf Of Niles, Scott
Sent: Thursday, April 19, 2018 2:25 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] NIH PO saying that approval is needed to move funds
I would agree with what Michael has said, but the phrasing of Carolyn’s question makes me think it was merely an example, and wasn’t pointedly referring to moving money in or out of equipment.
I’m curious about the phrase “as we discussed.” Are there intervening circumstances that you’re not privy to? Have you talked to the PI to get more specific information about his/her conversation with the PO?
Scott
Scott Niles, Ph.D., CRA
Research Associate/Contracting Officer
Office of Sponsored Programs
Georgia
Institute of
Technology
| GTRC
505 10th Street NW
Atlanta, GA 30332-0864
Office: 404-385-2080 Fax: 404-385-0864
Email:
xxxxxx@osp.gatech.edu Web: www.osp.gatech.edu
Secretary, NCURA Region III
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Michael Spires
Sent: Thursday, April 19, 2018 2:04 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] NIH PO saying that approval is needed to move funds
I’ve always simply assumed that transfers into or out of any budget line that is exempted from indirect costs (so, capital equipment, facilities or facility rental costs, participant support costs, tuition, etc.)
required prior approval from the sponsor, just because they had implications for the amount of indirect costs charged to the project. Outside those “protected” categories, sure—as long as you’re not changing the approved scope of work on the project or going
above any sponsor caps on the amount or percentage of award funds that can be moved around, you can rebudget as needed to complete the approved scope. But I always tread a little more cautiously in those protected categories.
Michael Spires, M.A., M.S., CRA
Research Development Officer, Sciences
The Research Office
Oakland University
256 Hannah Hall
244 Meadow Brook Road
Rochester, MI 48309-4451
(248) 370-2207
From: Research Administration List <xxxxxx@lists.healthresearch.org>
On Behalf Of Carolyn Elliott-Farino
Sent: Thursday, April 19, 2018 1:27 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] NIH PO saying that approval is needed to move funds
Happy almost Friday, and almost spring.
Can you think of any reason why an NIH program officer would tell a PI,
“As we discussed, you are free to use the funds from your personnel budget as you think best to achieve the aims of your R15 grant…. As we discussed, if you wanted to move funds from one section to the other (for example from equipment
to personnel), that is possible, but it would need a formal request and NINDS would evaluate and decide.”
My reading of NIH regs (copied below – no countermanding special conditions in the award) is that we don’t need permission to move funds from equipment to personnel, or
travel to supplies. Am I deluded? Mistaken? Did I miss something in the award notice? Or do we have a PO who is making me question what I thought I knew? Rather than assume my understanding was not faulty, I thought it prudent to check with the research admin
intelligentsia.
As always, thanks in advance.
Carolyn Elliott-Farino
Executive Director, Office of Research
Kennesaw State University
xxxxxx@kennesaw.edu; 470-578-6381
https://archives.nih.gov/asites/grants/11-14-2016/grants/policy/nihgps/nihgps.pdf
8.1 CHANGES IN PROJECT AND BUDGET
In general, NIH recipients are allowed a certain degree of latitude to rebudget within and between budget categories to meet unanticipated needs and to make other types of post-award changes. Some changes may
be made at the recipient’s discretion as long as they are within the limits established by NIH. In other cases, NIH prior written approval may be required before a recipient makes certain budget modifications or undertakes particular activities. The recipient-initiated
changes that may be made under the recipient’s authority and the changes that require NIH approval are outlined below and, with respect to particular types of awards, activities, or recipients, in Subpart IIB. In addition, individual awards may restrict recipients’
authorities to make budget and project changes without NIH prior approval. If NIH approval is required, it must be requested of, and obtained in writing from, the award- ing IC GMO in advance of the change or obligation of funds as specified later in this
chapter under Requests for Prior Approval.
Recipients shall immediately notify the Federal awarding agency of developments that have a significant impact on the award-supported activities. Also, notification shall be given in the case of problems, delays,
or adverse conditions which materially impair the ability to meet the objectives of the award.
This notification shall include a statement of the action taken or contemplated, and any assistance needed to resolve the situation.
Changes in project or budget resulting from NIH-initiated actions are discussed in other sections of this
chapter.
8.1.1 NIH Standard Terms of Award
Federal administrative requirements allow agencies to waive certain cost-related and administrative
prior approvals; these are known
as expanded authorities. In
2001, NIH extended expanded authorities to all NIH
awards except for the provision
to automatically carry over unobligated balances. Certain
award instruments, grant programs, and types
of recipients are routinely excluded from
the authority to auto- matically
carry over unobligated balances. This includes centers
(P50, P60, P30, and others); cooperative agreements (U); Kirschstein-NRSA institutional
research
training grants (T); non-Fast Track Phase 1 SBIR and STTR
awards (R43 and R41); clinical trials (regardless
of activity code); and
awards to indi- viduals.
One or more of these authorities may be overridden by a special term or condition of the award. Recip- ients must review the NoA to determine if a particular authority is withheld for a specific grant.
Recipients must exercise proper stewardship over Federal funds and ensure that costs charged to awards are allowable, allocable, reasonable, necessary, and consistently applied regardless of the source of funds.
NIH may disallow the costs if it determines, through audit or otherwise, that the costs do not meet the tests of allowability, allocability, reasonableness, necessity, and consistency.
Several authorities have specific deadlines for submission of reports or for timely notification to the NIH awarding IC. Recipients should be aware that any consistent pattern of failure to adhere to those dead-
lines for reporting or notification will be grounds for excluding that recipient from a specific authority.
Exhibit 6. Summary of NIH Standard Terms of Award
member’s regular departmental load.
And 45 CFR 75:
§75.308 Revision of budget and program plans.
(a) The approved budget for the Federal award summarizes the financial aspects of the project or program as approved during
the Federal award process. It may include either the Federal and non-Federal share (see §75.2 Federal share) or only the Federal share, depending upon HHS awarding agency requirements. It must be related to performance for program evaluation purposes
whenever appropriate.
(b) Recipients are required to report deviations from budget or project scope or objective, and request
prior approvals from HHS awarding agencies for budget and program plan revisions, in accordance with this section.
(c)(1) For non-construction Federal awards, recipients must request prior approvals from HHS awarding
agencies for one or more of the following program or budget-related reasons:
(i) Change in the scope or the objective of the project or program (even if there is no associated budget revision requiring
prior written approval).
(ii) Change in a key person specified in the application or the Federal award.
(iii) The disengagement from the project for more than three months, or a 25 percent reduction in time devoted to the
project, by the approved project director or principal investigator.
(iv) The inclusion, unless waived by the HHS awarding agency, of costs that require prior approval in accordance with
subpart E of this part, or appendix IX of this part, or 48 CFR part 31, as applicable.
(v) The transfer of funds budgeted for participant support costs as defined in §75.2 to other categories of expense.
(vi) Unless described in the application and funded in the approved Federal awards, the subawarding, transferring or contracting
out of any work under a Federal award, including fixed amount subawards as described in §75.353. This provision does not apply to the acquisition of supplies, material, equipment or general support services.
(vii) Changes in the approved cost-sharing or matching provided by the non-Federal entity.
(viii) The need arises for additional Federal funds to complete the project.
(ix) The inclusion of research patient care costs in research awards made for the performance of research work.
(x) The provision of subawards by a pass-through entity on fixed amounts up to the Simplified Acquisition Threshold, provided
that the subawards meet the requirements for fixed amount awards in §75.201. See §75.353.
(xi) The recipient wishes to dispose of, replace, or encumber title to real property, equipment, or intangible property
that are acquired or improved with a Federal award. See §§75.318, 75.320, 75.322, and 75.323.
(2) No other prior approval requirements for specific items may be imposed unless an exception has been approved by OMB.
See also §§75.102 and 75.407.
(d) Except for requirements listed in paragraph (c)(1) of this section, the HHS awarding agencies are authorized, at their
option, to waive prior written approvals required by paragraph (c) this section. Such waivers may include authorizing recipients to do any one or more of the following:
(1) Incur project costs 90 calendar days before the HHS awarding agency makes the Federal award. Expenses more than 90
calendar days pre-award require prior approval of the HHS awarding agency. All costs incurred before the HHS awarding agency makes the Federal award are at the recipient's risk (i.e., the HHS awarding agency is under no obligation to reimburse such
costs if for any reason the recipient does not receive a Federal award or if the Federal award is less than anticipated and inadequate to cover such costs). See also §75.458.
(2) Initiate a one-time extension of the period of performance by up to 12 months unless one or more of the conditions
outlined in paragraphs (d)(2)(i) through (iii) of this section apply. For one-time extensions, the recipient must notify the HHS awarding agency in writing with the supporting reasons and revised period of performance at least 10 calendar days before the end
of the period of performance specified in the Federal award. This one-time extension may not be exercised merely for the purpose of using unobligated balances. Extensions require explicit prior HHS awarding agency approval when:
(i) The terms and conditions of the Federal award prohibit the extension.
(ii) The extension requires additional Federal funds.
(iii) The extension involves any change in the approved objectives or scope of the project.
(3) Carry forward unobligated balances to subsequent periods of performance.
(4) For Federal awards that support research, unless the HHS awarding agency provides otherwise in the Federal award or
in the HHS awarding agency's regulations, the prior approval requirements described in paragraph (d) are automatically waived (i.e., recipients need not obtain such prior approvals) unless one of the conditions included in paragraph (d)(2) applies.
(e) The HHS awarding agency
may, at its option, restrict the transfer of funds among direct cost categories or programs, functions and activities for Federal awards in which the Federal share of the project exceeds the Simplified Acquisition Threshold and the cumulative amount
of such transfers exceeds or is expected to exceed 10 percent of the total budget as last approved by the HHS awarding agency. The HHS awarding agency cannot permit a transfer that would cause any Federal appropriation to be used for purposes other than those
consistent with the appropriation.
(f) All other changes to non-construction budgets, except for the changes described in paragraph (c) of this section,
do not require prior approval (see also §75.407).
(g) For construction Federal awards, the recipient must request prior written approval promptly from the HHS awarding
agency for budget revisions whenever paragraph (g)(1), (2), or (3) of this section applies.
(1) The revision results from changes in the scope or the objective of the project or program.
(2) The need arises for additional Federal funds to complete the project.
(3) A revision is desired which involves specific costs for which prior written approval requirements may be imposed consistent
with applicable OMB cost principles listed in subpart E of this part.
(4) No other prior approval requirements for budget revisions may be imposed unless an exception has been approved by
OMB.
(5) When an HHS awarding agency makes a Federal award that provides support for construction and non-construction work,
the HHS awarding agency may require the recipient to obtain prior approval from the HHS awarding agency before making any fund or budget transfers between the two types of work supported.
(h) When requesting approval for budget revisions, the recipient must use the same format for budget information that
was used in the application, unless the HHS awarding agency indicates a letter of request suffices.
(i) Within 30 calendar days from the date of receipt of the request for budget revisions, the HHS awarding agency must
review the request and notify the recipient whether the budget revisions have been approved. If the revision is still under consideration at the end of 30 calendar days, the HHS awarding agency must inform the recipient in writing of the date when the recipient
may expect the decision.
(j) All approvals granted in keeping with the provisions of this section shall not be valid unless they are in writing,
and signed by at least one of the following HHS officials:
(1) The Head of the HHS awarding agency that made the award or subordinate official with proper delegated authority from
the Head, including the Head of the Regional Office of the HHS awarding agency that made the award; or
(2) The responsible Grants Officer of the HHS awarding agency that made the award or an individual duly authorized by
the Grants Officer.
[79 FR 75889, Dec. 19, 2014, as amended at 81 FR 3016, Jan. 20, 2016]
https://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75#se45.1.75_1308
= = = = = =
Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at
http://www.healthresearch.org (click on the "RESADM-L" link under "Sponsored Programs").
A link directly to helpful tips:
http://tinyurl.com/resadm-l-help
= = = = = =
= = = = = =
Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at
http://www.healthresearch.org (click on the "RESADM-L" link under "Sponsored Programs").
A link directly to helpful tips:
http://tinyurl.com/resadm-l-help
= = = = = =
= = = = = =
Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at
http://www.healthresearch.org (click on the "RESADM-L" link under "Sponsored Programs").
A link directly to helpful tips:
http://tinyurl.com/resadm-l-help
= = = = = =